Sun Pharma Advanced Research Company Share Price
Small Cap | Pharmaceuticals and health care | NSE: SPARC | BSE: 532872
₹129.45 -5.80 (-4.29 %)
Last Updated: 21 Feb 2025 04:01 PM
Overview
Open (₹) 132.70
High (₹) 136.65
Low (₹) 128.35
Prev. Close (₹) 135.25
Volume 1,27,905
VWAP (₹) 131.09
ROCE (%) -154.06
Industry P/E 61.12
TTM P/E -10.81
P/B Ratio 33.36
Market Cap (₹) Cr.4,200.28
Dividend Yield (%)--
EPS (₹) -11.93
ROE-307.47%
Sales Growth (%) -68.36
Profit Growth (%)73.96
Day Range
136.65136.65
52 Week Range
127.95474.00
Historical Returns
Returns (6M)
-44.37 %
Returns (1Y)
-63.87 %
Returns (3Y)
-53.37 %
Returns (5Y)
-19.85 %
Returns (6M)
-44.37 %
Returns (1Y)
-63.87 %
Returns (3Y)
-53.37 %
Returns (5Y)
-19.85 %
SWOT Analysis
- Company with (52.56%) TTM EPS Growth
- Company with Low Debt
- Growth in Net Profit Margin (QoQ)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
Technicals
Technical Rating
RSI 40.42
MFI 26.66
ATR 6.92
Commodity Channel Index -122.70
ROC125 -41.95
ROC21 -24.30
Williams %R -95.70
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 134.61 | 139.78 | 142.91 | 131.48 | 126.31 | 123.18 | 118.01 |
Week Ago | 146.99 | 152.82 | 158.29 | 141.52 | 135.69 | 130.22 | 124.39 |
Month Ago | 180.80 | 184.60 | 187.55 | 177.85 | 174.05 | 171.10 | 167.30 |
EMA & SMA
129.45
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 134.31
9 Day 140.74
10 Day 143.19
12 Day 146.85
14 Day 147.46
20 Day 150.85
26 Day 157.14
50 Day 178.10
100 Day 193.64
200 Day 208.90
Deals & Announcements
Bulk and Block Deals
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
24 Feb, 2023 | SUDHIR VALIA | Pledge | ₹190.80 | 18,00,000 | BSE |
24 Feb, 2023 | RAKSHA VALIA | Pledge | ₹190.80 | 22,00,000 | BSE |
12 Jan, 2023 | Dilip S. Shanghvi | Disposal | ₹ | 2,52,80,899 | BSE |
12 Jan, 2023 | Dilip S. Shanghvi | Acquisition | ₹133.5000000197777776810864202 | 2,52,80,899 | BSE |
28 Dec, 2022 | RAKSHA VALIA | Pledge | ₹213.80 | 19,00,000 | BSE |
05 Dec, 2022 | Raksha Valia | Pledge | ₹250.70 | 30,80,000 | BSE |
01 Sept, 2022 | Raksha Valia | Pledge | ₹229.40 | 10,00,000 | BSE |
21 Jun, 2022 | RAKSHA VALIA | Pledge | ₹174.20 | 4,30,000 | BSE |
20 Jun, 2022 | RAKSHA VALIA | Pledge | ₹204.40 | 8,70,000 | BSE |
24 May, 2022 | RAKSHA VALIA | Pledge | ₹216.85 | 13,00,000 | BSE |
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
12 Feb, 2025 | NSE India | Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication pertaining to financial results of Q3 FY 25 |
10 Feb, 2025 | BSE India | Integrated filing (Financial) for the quarter and nine months ended December 31, 2024 |
10 Feb, 2025 | NSE India | Integrated Financials |
10 Feb, 2025 | NSE India | Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Outcome of Board Meeting held on February 10, 2025. |
10 Feb, 2025 | BSE India | Outcome of the Board Meeting |
10 Feb, 2025 | BSE India | Financial Results for the quarter and nine months ended December 31, 2024 |
10 Feb, 2025 | NSE India | Sun Pharma Advanced Research Company Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
31 Jan, 2025 | NSE India | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . |
31 Jan, 2025 | BSE India | SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 ,inter alia, to consider and approve financial results for the quarter and nine months ended December 31, 2024 |
17 Jan, 2025 | NSE India | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 01 Feb, 2025 | 10 Feb, 2025 |
Quarterly Results | -- | 28 Oct, 2024 | 04 Nov, 2024 |
Quarterly Results | -- | 30 Jul, 2024 | 05 Aug, 2024 |
Audited Results | -- | 21 May, 2024 | 24 May, 2024 |
Quarterly Results | -- | 24 Jan, 2024 | 05 Feb, 2024 |
Quarterly Results | -- | 30 Oct, 2023 | 06 Nov, 2023 |
Quarterly Results | -- | 02 Aug, 2023 | 07 Aug, 2023 |
Audited Results & Others | To consider Fund Raising | 21 May, 2023 | 22 May, 2023 |
Quarterly Results | -- | 07 Feb, 2023 | 13 Feb, 2023 |
Quarterly Results | -- | 31 Oct, 2022 | 07 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Sun Pharma Advanced Research Company
Sun Pharma Advanced Research Company is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837. Currently Company is involved in the business activities of Research and experimental development on natural sciences and engineering. Company’s Total Operating Revenue is Rs. 75.55 Cr. and Equity Capital is Rs. 32.45 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2006
Managing Director
-- --
NSE Symbol
SPARC
Sun Pharma Advanced Research Company Management
Name | Designation |
---|---|
Mr. Dilip S Shanghvi | Chairman & Non-Exe.Director |
Dr. T Rajamannar | Non Executive Director |
Dr. Robert J Spiegel | Independent Director |
Mr. Sudhir V Valia | Non Executive Director |
Ms. Bhavna Doshi | Independent Director |
Dr. Ferzaan Engineer | Independent Director |
Ms. Vidhi Shanghvi | Non Exe.Non Ind.Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Syngene Intl | ₹34,229.73 | ₹713.75 ₹714.60(-0.12%) | ₹608.000 - ₹960.000 |
SPARC | ₹6,538.46 | ₹129.43 ₹135.25(-4.30%) | ₹189.450 - ₹474.000 |
Suven Life | ₹2,798.32 | ₹117.60 ₹118.45(-0.72%) | ₹80.100 - ₹169.000 |
Vimta Labs | ₹2,215.44 | ₹946.75 ₹965.65(-1.96%) | ₹400.150 - ₹1,070.550 |
Choksi Labs | ₹45.34 | ₹129.00 ₹131.50(-1.90%) | ₹38.320 - ₹94.000 |
FAQs on Sun Pharma Advanced Research Company
What is the share price of Sun Pharma Advanced Research Company?
The share price of Sun Pharma Advanced Research Company on 21 Feb, 2025 is ₹ 129.45.
What is 52W high and 52W low share price of Sun Pharma Advanced Research Company?
The highest and lowest 52W share prices of Sun Pharma Advanced Research Company are ₹ 474.000 and ₹ 189.450
What is the market cap of Sun Pharma Advanced Research Company?
The market capitalization of Sun Pharma Advanced Research Company as of 21 Feb, 2025 is ₹ 4,200.28 Crores
What is the P/E ratio of Sun Pharma Advanced Research Company?
The current P/E ratio of Sun Pharma Advanced Research Company as of 21 Feb, 2025 is 61.12
What is the PB ratio of Sun Pharma Advanced Research Company?
The PB ratio of Sun Pharma Advanced Research Company as of 21 Feb, 2025 is 33.36
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)